Clinical Trial Update: Pharmacokinetics of Propofol in Morbidly Obese Patients [Phase 4]

View source ↗

Summary

A completed Phase 4 pharmacokinetics study examining how propofol is absorbed, distributed, and eliminated in morbidly obese patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Morbid Obesity

Drugs mentioned

• PROPOFOL (Propofol)

Snippet

Sponsor: Oslo University Hospital | Conditions: Obesity, Morbid | Phase 4 | Status: COMPLETED